G 蛋白抑制剂 YM-254890 是一种聚类粘合剂
Tony Trent1, Justin J Miller1, Kendall J Blumer1
1Department of Biochemistry, Biophysics, and Chemical Biology, University of Pennsylvania, Philadelphia, PA 19104-6059, United States.
Journal of molecular biology
|March 15, 2025
概括
了解YM-254890如何抑制G蛋白是开发新药的关键. 对于YM敏感的G蛋白是预先有组织的,用于结合,Gβγ充当全稳定剂.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- G蛋白结合受体 (GPCR) 是重要的药物标.
- 准G蛋白,GPCR的下游效应剂,提供了一个替代的治疗策略.
- 自然产品YM-254890抑制Gq/11,突出显示了G蛋白特异性抑制剂的潜力.
研究的目的:
- 阐明YM-254890在G蛋白上的抑制机制.
- 调查G蛋白异型选择性中构造动态的作用.
- 引导开发新型,高特异性的G蛋白抑制剂.
主要方法:
- 模拟G蛋白异型 (Gα子单元和Gαβγ异体) 的分子动力学模拟.
- 马尔科夫状态模型 (MSM) 的构建和分析,以表征构造性景观.
- 计算分析YM-254890的结合性和性效应.
主要成果:
- 与不敏感的异形相比,对YM敏感的Gα子单元对YM结合的构造具有更高的倾向.
- 在Gα上的YM和Gβγ结合位之间存在显著的全结合.
- Gβγ 结合增强了 Gα 对 YM 结合的预组织,表明了积极的合作性.
结论:
- YM-254890作为一种"全性",稳定了Gα-Gβγ复合体.
- 形状上的差异和全性机制决定了YM的G蛋白异型选择性.
- 这些发现为设计未来的G蛋白向治疗提供了机制基础.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
Activation and Inactivation of G Proteins
6.5K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.5K
Allosteric Regulation
57.4K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
506
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
506


